AU2001258662A1 - Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds - Google Patents

Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds

Info

Publication number
AU2001258662A1
AU2001258662A1 AU2001258662A AU5866201A AU2001258662A1 AU 2001258662 A1 AU2001258662 A1 AU 2001258662A1 AU 2001258662 A AU2001258662 A AU 2001258662A AU 5866201 A AU5866201 A AU 5866201A AU 2001258662 A1 AU2001258662 A1 AU 2001258662A1
Authority
AU
Australia
Prior art keywords
eye
lacrophyl
active substance
active compounds
therapeutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258662A
Other languages
English (en)
Inventor
Ilona Molnarne Kahan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001258662A1 publication Critical patent/AU2001258662A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001258662A 2000-05-04 2001-05-04 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds Abandoned AU2001258662A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0001769 2000-05-04
HU0001769A HUP0001769A2 (hu) 2000-05-04 2000-05-04 Lakrofil készítmény alkalmazása gyógyászati hatóanyag-tartalmú szemcseppekben
PCT/HU2001/000053 WO2001082893A1 (en) 2000-05-04 2001-05-04 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds

Publications (1)

Publication Number Publication Date
AU2001258662A1 true AU2001258662A1 (en) 2001-11-12

Family

ID=89978306

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258662A Abandoned AU2001258662A1 (en) 2000-05-04 2001-05-04 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds

Country Status (9)

Country Link
US (1) US6949241B2 (de)
EP (1) EP1278511B1 (de)
AT (1) ATE272389T1 (de)
AU (1) AU2001258662A1 (de)
CA (1) CA2407794A1 (de)
DE (1) DE60104670T2 (de)
ES (1) ES2248326T3 (de)
HU (1) HUP0001769A2 (de)
WO (1) WO2001082893A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229814A1 (en) * 2002-08-28 2004-11-18 James Dillon Methods and compositions for protecting against cataract development associated with vitrectomies
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US20060275278A1 (en) * 2005-06-02 2006-12-07 Choy Camus K M Method and ophthalmic formulation for eye protection or treatment
EP2035015A4 (de) * 2006-05-01 2009-11-11 Riolan Technologies Inc Zusammensetzungen, verfahren und kits zur behandlung des trockenen auges
EP2134355A4 (de) * 2007-03-02 2012-01-11 Saint Simeon Lda Neue ophthalmische zusammensetzungen mit humanem rekombinantem lysozym und ihre verwendung zur behandlung von augenerkrankungen und als kontaktlinsenlösungen
CN103182075B (zh) * 2011-12-30 2015-07-22 沈阳兴齐眼药股份有限公司 一种溶菌酶制剂、其制备方法及用途
JP6867288B2 (ja) 2014-07-21 2021-04-28 エーエムディー セラピューティックス エルエルシー リファマイシンの眼科用組成物およびその使用
CN114365792A (zh) 2014-11-11 2022-04-19 克莱拉食品公司 用于生成卵清蛋白的方法和组合物
WO2017209721A1 (en) 2016-06-02 2017-12-07 Alemdar Eda A drug derived from enzymes present in the human saliva for use in preventing corneal clouding or cataract formation
KR20220034848A (ko) 2019-07-11 2022-03-18 클라라 푸드즈 컴퍼니 단백질 조성물 및 이의 섭취 가능한 제품
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
WO2022138639A1 (ja) * 2020-12-21 2022-06-30 ビーエヌシー コリア カンパニー,リミテッド リファマイシンの眼科用組成物およびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
HU209538B (en) * 1990-05-09 1994-07-28 Vepex Contractor Ltd Set and cleaning composition for treating contactlenses

Also Published As

Publication number Publication date
HUP0001769A2 (hu) 2002-01-28
EP1278511A1 (de) 2003-01-29
ES2248326T3 (es) 2006-03-16
WO2001082893A1 (en) 2001-11-08
US6949241B2 (en) 2005-09-27
CA2407794A1 (en) 2001-11-08
ATE272389T1 (de) 2004-08-15
EP1278511B1 (de) 2004-08-04
US20030124112A1 (en) 2003-07-03
HU0001769D0 (en) 2000-07-28
DE60104670D1 (de) 2004-09-09
DE60104670T2 (de) 2005-01-13

Similar Documents

Publication Publication Date Title
AU2525401A (en) Use of an extract of at least one vaccinium-type plant as an anti-glycation agent
AU2001258662A1 (en) Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds
EP1093819A3 (de) Verbindungen und Arzneizusammensetzungen zur Verabreichung von Wirkstoffen
AU4711296A (en) Method for loading lipid vesicles
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
ATE311227T1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
DK1283700T3 (da) Farmaceutiske sustained release-præparater til parenteral administration af biologisk aktive hydrofile forbindelser
AU2845599A (en) Pharmaceutical compositions and their use
WO2000007979A3 (en) Compounds and compositions for delivering active agents
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
AU2274201A (en) Compounds and compositions for delivering active agents
AU3956599A (en) Surfactant for use in external preparations for skin and external preparation for skin containing the same
WO1998037872A3 (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
EP1003526A4 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendung
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
CA2361402A1 (en) Bis-sulfonamides
ITMI20020189A1 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AU2001289714A1 (en) Benzofuran derivatives and their use as antibacterial agents
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ES2188021T3 (es) Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.
CA2395438A1 (en) Dry compositions containing hydrophobic amino acid
DK0934342T3 (da) Præparat indeholdende chitosan